Find, compare & contact
Ethosuximide
API Manufacturers & Suppliers
India
Netherlands
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Ethosuximide API 77-67-8?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Ethosuximide. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Ethosuximide
- Synonyms:
- Aethosuximide , Atysmal , Ethosuximid , Ethosuximide , Ethosuximidum , Etosuximida , gamma-Ethyl-gamma-methyl-succinimide , gamma-Methyl-gamma-ethyl-succinimide , Thilopemal
- Cas Number:
- 77-67-8
- DrugBank number:
- DB00593
- Unique Ingredient Identifier:
- 5SEH9X1D1D
About Ethosuximide
So, what does it do? An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
Ask the supplier for a certificate of analysis to find out more about the quality of Ethosuximide.
Ethosuximide is a type of Antiepileptics
Antiepileptics, also known as antiseizure or anticonvulsant drugs, belong to the pharmaceutical category of active pharmaceutical ingredients (APIs) used for the treatment of epilepsy and other seizure disorders. These medications work by modulating the activity of neurotransmitters and ion channels in the brain to prevent or reduce the occurrence of seizures.
Antiepileptic APIs are classified into various chemical classes, including hydantoins, barbiturates, benzodiazepines, succinimides, and others. Each class of antiepileptics exerts its therapeutic effects through distinct mechanisms, targeting different components of the brain's neural network involved in seizure generation and propagation.
These APIs are typically formulated into oral tablets, capsules, or liquids for easy administration. Some antiepileptic drugs are also available in injectable forms for emergency situations. The dosage and treatment duration vary based on the patient's age, seizure type, and medical history.
The development of antiepileptic APIs requires rigorous research, including preclinical and clinical trials, to establish safety, efficacy, and optimal dosing regimens. Pharmaceutical companies follow strict quality control standards to ensure the purity, stability, and consistent quality of these APIs.
While antiepileptics are primarily used for epilepsy management, they are also prescribed for other neurological conditions such as bipolar disorder, neuropathic pain, and migraine prophylaxis. However, it is important to note that these medications may have potential side effects, including drowsiness, dizziness, cognitive impairment, and mood changes, which should be carefully monitored by healthcare professionals.
In conclusion, antiepileptics represent a crucial category of pharmaceutical APIs utilized in the treatment of epilepsy and other seizure disorders. These drugs play a vital role in managing and improving the quality of life for individuals affected by these conditions, helping to reduce the frequency and severity of seizures.
